시장보고서
상품코드
2051329

듀얼 챔버 프리필드 시린지 시장 : 제품 유형별, 재질별, 적응증별, 유통 채널별, 지역별

Dual Chamber Prefilled Syringes Market, By Product Type, By Material Type, By Indication, By Distribution Channel, By Geography

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 6,990,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,873,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 15,534,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

듀얼 챔버 프리필드 시린지 시장은 2026년에 1억 9,890만 달러로 추정되고, 2033년까지 3억 3,430만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 7.7%를 기록할 전망입니다.

보고서 범위 보고서 상세
기준 연도 : 2025년 2026년 시장 규모 : 1억 9,890만 달러
과거 데이터 기간 : 2020-2024년 예측 기간 : 2026-2033년
예측 기간(2026-2033년) CAGR : 7.70% 2033년 시장 규모 예측 : 3억 3,430만 달러

듀얼 챔버 프리필드시린지는 한 번의 투여로 두 가지 다른 의약품 성분 또는 약물을 투여하는 데 사용되는 의료기기입니다. 이들은 주사기 배럴 내부에 물리적 칸막이로 분리된 두 개의 챔버를 갖추고 있습니다. 한쪽 챔버에는 액체 상태의 약제 성분이, 다른 한쪽 챔버에는 동결건조 또는 분말 상태의 약제 성분이 들어 있습니다. 플런저를 누르면 주사하기 전에 이 두 성분이 균일하게 혼합됩니다. 그 주요 장점은 장시간 접촉하면 효능을 잃는 불안정한 약물이나 화합물을 혼합할 수 있다는 점입니다. 재료와 디자인의 발전으로 듀얼 챔버 프리필드시린지는 정확한 약물 투여, 사용 편의성, 보관 및 운송 중 안정성을 향상시켰습니다.

시장 역학

세계 듀얼 챔버 프리필드 주사기 시장의 성장은 비경구 약물 전달에 대한 수요 증가, 프리필드 주사기의 자가 투여 증가, 병용 요법에 대한 관심 증가에 힘입어 성장하고 있습니다. 생물학적 제제나 고분자 의약품도 투여 전 혼합이 필요한 경우가 많아 시장 성장에 크게 기여하고 있습니다. 그러나 설계, 제조 및 사용성 테스트에 대한 엄격한 규제가 시장 성장을 저해할 수 있습니다. 또한, 대체 약물 전달 수단의 존재가 경쟁요인으로 작용하고 있습니다. 지속적인 연구개발을 통해 적응증이 확대되고 있으며, 이 투여 시스템을 검토하는 신규 진출기업에게는 매력적인 기회가 될 것입니다.

본 조사의 주요 특징

  • 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
  • 이 보고서는 세계 듀얼 챔버 프리필드시린지 주사기 시장의 주요 기업 프로파일을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략 등 다양한 매개 변수를 기반으로 작성되었습니다.
  • 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
  • 세계 듀얼 챔버 프리필드 주사기 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 듀얼 챔버 프리필드 주사기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 듀얼 챔버 프리필드 시린지 시장 : 제품 유형별, 2021년-2033년

제5장 세계의 듀얼 챔버 프리필드 시린지 시장 : 소재 유형별, 2021년-2033년

제6장 세계의 듀얼 챔버 프리필드 시린지 시장 : 적응증별, 2021년-2033년

제7장 세계의 듀얼 챔버 프리필드 시린지 시장 : 유통 채널별, 2021년-2033년

제8장 세계의 듀얼 챔버 프리필드 시린지 시장 : 지역별, 2021년-2033년

제9장 경쟁 구도

제10장 애널리스트의 제안

제11장 참고 문헌 및 조사 방법

LSH 26.06.18

Dual Chamber Prefilled Syringes Market is estimated to be valued at USD 198.9 Mn in 2026 and is expected to reach USD 334.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 198.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.70% 2033 Value Projection: USD 334.3 Mn

Dual chamber prefilled syringes are medical devices that are used for delivering two separate pharmaceutical compounds or drugs in a single administration. These have two chambers separated by a physical barrier inside the syringe barrel. One chamber contains the liquid drug component while the other holds the lyophilized or powder drug component. When the plunger is pressed, these two components are mixed homogeneously before injection. Its main advantage is the ability to mix unstable drugs or compounds that lose potency when in contact for a prolonged period. With advancements in materials and design, dual chamber prefilled syringes offer accurate drug dosing, ease of use, and enhanced stability during storage and transport.

Market Dynamics

Global dual chamber prefilled syringes market growth is driven by growing demand for parenteral drug delivery, rise in self-administration of prefilled syringes, and increasing focus on combination therapies. Biologics and large molecule drugs also contribute significantly as these often require mixing prior to injection. However, stringent regulations pertaining to design, manufacturing and usability testing can hamper the market growth. Furthermore, availability of alternative drug delivery modes provides competition. Ongoing research and development will expand indications and new entrants exploring this delivery system present attractive opportunities.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global dual chamber prefilled syringes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study Pfizer Inc., NIPRO PHARMA CORPORATION, Gerresheimer AG, Vetter Pharma, Credence MedSystems, Inc., ARTE Corporation, BD, MAEDA INDUSTRY Co., Ltd., Bayer, Stevanato Group, Elcam Drug Delivery Devices, SCHOTT Pharma, OndrugDelivery Ltd, Catalent, Inc, and Datwyler Holding Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global dual chamber prefilled syringes market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dual chamber prefilled syringes market.

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Conventional Prefilled Syringes
  • Safety Prefilled Syringes
  • Material Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Glass
  • Plastic
  • Indication Insights (Revenue, USD Mn, 2021 - 2033)
  • Hemophilia
  • Schizophrenia
  • Diabetes
  • Erectile Dysfunction
  • Others
  • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Pfizer Inc.
  • NIPRO PHARMA CORPORATION
  • Gerresheimer AG
  • Vetter Pharma
  • Credence MedSystems, Inc.
  • ARTE Corporation
  • BD
  • MAEDA INDUSTRY Co., Ltd.
  • Bayer
  • Stevanato Group
  • Elcam Drug Delivery Devices
  • SCHOTT Pharma
  • OndrugDelivery Ltd
  • Catalent, Inc
  • Datwyler Holding Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Material Type
    • Market Snapshot, By Indication
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Pricing Analysis
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Fundings and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Dual Chamber Prefilled Syringes Market, By Product Type, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Conventional Prefilled Syringes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Safety Prefilled Syringes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Dual Chamber Prefilled Syringes Market, By Material Type, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Glass
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Plastic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Dual Chamber Prefilled Syringes Market, By Indication, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hemophilia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Schizophrenia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Diabetes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Erectile Dysfunction
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Dual Chamber Prefilled Syringes Market, By Distribution Channel, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Dual Chamber Prefilled Syringes Market, By Region, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • NIPRO PHARMA CORPORATION
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Gerresheimer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Vetter Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Credence MedSystems, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ARTE Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BD
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • MAEDA INDUSTRY Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bayer
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Stevanato Group
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Elcam Drug Delivery Devices
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SCHOTT Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • OndrugDelivery Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Catalent, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Datwyler Holding Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기